Supervisory Board

Benoit Barteau

Board Member

Benoit BARTEAU (PhD) is Senior Investment Manager in the Life Sciences Department of Bpifrance Investissement. Since 2014, he has been involved in around 10 investment deals. Prior to Bpifrance, Benoit has gained over 7 years...

Frédéric Chereau

Board member

Frederic Chereau currently serves as President and Chief Executive Officer of LogicBio Therapeutics. From 2014 to 2015, Mr. Chereau was President and Chief Operating Officer of aTyr Pharma (LIFE). During his tenure, the company advanced multiple...

Rémi Droller

Board member

Rémi Droller has a master’s degree in Molecular Biology (Paris VI) and master’s degree in Finance and Innovation Management (Masternova – AgroPariTech). He started at CDC Innovation from 2000 to 2003 and later joined AGF Private...

Georges Gemayel

Chairman

Georges Gemayel has 30 years of experience in the biopharmaceutical industry. He serves currently as Chairman of the Board of Directors of Dynacure, Oxthera, Enterome and Orphazyme.  Georges serves also as Director of Momenta Pharmaceuticals...

Ohad Hammer

Board Member

Ohad is a Partner at Pontifax, where he is in charge of scouting and project evaluation. In his role at Pontifax, Ohad is also involved in the formation and development strategy of the fund’s early-stage...

Chris Mirabelli

Board member

Chris Mirabelli (PhD) has served as the Chairman of the Board of Directors of Leap Therapeutics (LPTX) since 2016 and has also served as the President and Chief Executive Officer since the company’s inception in 2011....

Brett P. Monia

Board member

Brett P. Monia (PhD) is a founding member of Ionis Pharmaceuticals (IONS) and the COO of the company. Dr. Monia was also the Franchise Leader for programs in Oncology and Rare Genetic Diseases at Ionis Pharmaceuticals....

Stéphane van Rooijen

Board member

Stephane van Rooijen (MD, MBA) is a general management biotech executive with in-depth experience in life sciences working across European and North American organizations. He studied medicine at KU Leuven and obtained an MBA at Erasmus...

Raphael Wisniewski

Board Member

Raphael joined the Life Sciences Team of Andera Partners (formerly Edmond de Rothschild Investment Partners) in 2001. Previously, he worked in Healthcare Corporate Finance at Goldman Sachs starting at Salomon Smith Barney. He worked also...